Company news
Diamyd Medical Ab Class B (OMXSTO:DMYD_B) news
Diamyd Medical Ab Class B news releases on 6ix. Latest, Mar 23, 2026: Diamyd Medical enters into equity financing agreements with new U.S. sector specialist…
Press releases & updates
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial
March 23, 2026
Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial
February 24, 2026
Diamyd Medical receives Notice of Allowance for key retogatein US patent
February 9, 2026
Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance
December 29, 2025